Concepedia

Vishwas Paralkar

VP

Statistics

Publications

45

Citations

3.8K

H-Index

33

Active since

1989

Affiliations

Pfizer (United States)(Current)

National Institutes of Health

National Institute of Dental and Craniofacial Research

University of Zagreb

Vion Pharmaceuticals (United States)

Vishwas Paralkar is an author at Pfizer (United States) specializing in medicine, cell biology, and osteoporosis.

ORCID

Top concepts

Publications per year

1989–2022

45

Publications

45

Transforming growth factor β type 1 binds to collagen IV of basement membrane matrix: Implications for development

Vishwas Paralkar, Slobodan Vukičević, A. Hari Reddi · Developmental Biology · 1991 · 355 citations

, , +9

Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption

Hua Zhu Ke, Hong Qi, A. Frederik Weidema et al. · Molecular Endocrinology · 2003 · 289 citations · Full text

, , +18

Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family

Vishwas Paralkar, Amy L. Vail, W A Grasser et al. · Journal of Biological Chemistry · 1998 · 288 citations · Full text

Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression.

N. S. Cunningham, Vishwas Paralkar, A. Hari Reddi · Proceedings of the National Academy of Sciences · 1992 · 238 citations · Full text

, , +21

An EP2 receptor-selective prostaglandin E<sub>2</sub>agonist induces bone healing

Vishwas Paralkar, Fran Borovečki, H.Z. Ke et al. · Proceedings of the National Academy of Sciences · 2003 · 185 citations · Full text

, , +11

1–5 of 45